Cargando…

HIV-DNA in the Genital Tract of Women on Long-Term Effective Therapy Is Associated to Residual Viremia and Previous AIDS-Defining Illnesses

OBJECTIVES: To assess the impact of long-term combined antiretroviral therapy (cART) on HIV-RNA and HIV-DNA levels in cervicovaginal secretions of HIV-1-infected women with sustained undetectable plasma RNA viral load (PVL); to explore factors predictive of residual viral shedding; and to evaluate t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prazuck, Thierry, Chaillon, Antoine, Avettand-Fènoël, Véronique, Caplan, Anne-Laure, Sayang, Collins, Guigon, Aurélie, Niang, Mohamadou, Barin, Francis, Rouzioux, Christine, Hocqueloux, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749193/ https://www.ncbi.nlm.nih.gov/pubmed/23990886 http://dx.doi.org/10.1371/journal.pone.0069686

Ejemplares similares

Dolutegravir-based monotherapy or dual therapy maintains a high proportion of viral suppression even in highly experienced HIV-1-infected patients
por: Gubavu, Camelia, et al.
Publicado: (2016)

S03-04 OA. Transitional and central memory CD4 T cells are highly infected in long term non progressors and elite controllers
por: Descours, B, et al.
Publicado: (2009)

Total HIV DNA: a global marker of HIV persistence
por: Rouzioux, Christine, et al.
Publicado: (2018)

Pro-viral DNA and antiretroviral treatment simplification
por: Zucman, D, et al.
Publicado: (2010)

Finger-Stick Whole Blood HIV-1/-2 Home-Use Tests Are More Sensitive than Oral Fluid-Based In-Home HIV Tests
por: Jaspard, Marie, et al.
Publicado: (2014)

NKG2C(+) memory-like NK cells contribute to the control of HIV viremia during primary infection: Optiprim-ANRS 147
por: Gondois-Rey, Françoise, et al.
Publicado: (2017)

In-Depth Characterization of Full-Length Archived Viral Genomes after Nine Years of Posttreatment HIV Control
por: Trémeaux, Pauline, et al.
Publicado: (2023)

Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study
por: Sáez-Cirión, Asier, et al.
Publicado: (2013)

A Subset of Extreme Human Immunodeficiency Virus (HIV) Controllers Is Characterized by a Small HIV Blood Reservoir and a Weak T-Cell Activation Level
por: Canouï, Etienne, et al.
Publicado: (2017)

CD4 Dynamics over a 15 Year-Period among HIV Controllers Enrolled in the ANRS French Observatory
por: Boufassa, Faroudy, et al.
Publicado: (2011)

HIV-Specific B Cell Frequency Correlates with Neutralization Breadth in Patients Naturally Controlling HIV-Infection
por: Rouers, Angeline, et al.
Publicado: (2017)

Gag-Specific CD4 and CD8 T-Cell Proliferation in Adolescents and Young Adults with Perinatally Acquired HIV-1 Infection Is Associated with Ethnicity — The ANRS-EP38-IMMIP Study
por: Le Chenadec, Jérôme, et al.
Publicado: (2015)

Gag-Specific CD8 T-Cell Proliferation Is Associated With Higher Peripheral Blood Levels of Transforming Growth Factor-β and Gut-Homing T Cells in Youths Perinatally Infected With Human Immunodeficiency Virus-1: The ANRS-EP38-IMMIP Study
por: Warszawski, Josiane, et al.
Publicado: (2016)

Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3
por: Sarracino, Ambra, et al.
Publicado: (2018)

Increasing contribution of integrated forms to total HIV DNA in blood during HIV disease progression from primary infection
por: Trémeaux, Pauline, et al.
Publicado: (2019)

Distinct Genetic Loci Control Plasma HIV-RNA and Cellular HIV-DNA Levels in HIV-1 Infection: The ANRS Genome Wide Association 01 Study
por: Dalmasso, Cyril, et al.
Publicado: (2008)

Plasma HIV-2 RNA According to CD4 Count Strata among HIV-2-Infected Adults in the IeDEA West Africa Collaboration
por: Ekouévi, Didier K., et al.
Publicado: (2015)

Dynamics in HIV‐DNA levels over time in HIV controllers
por: Avettand‐Fenoel, Véronique, et al.
Publicado: (2019)

Impact of early cART on HIV blood and semen compartments at the time of primary infection
por: Chéret, Antoine, et al.
Publicado: (2017)

Spatiotemporal dynamics of HIV-1 transmission in France (1999–2014) and impact of targeted prevention strategies
por: Chaillon, Antoine, et al.
Publicado: (2017)

What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSM
por: Bendenoun, M., et al.
Publicado: (2017)

Investigation of a family outbreak of COVID-19 using systematic rapid diagnostic tests raises new questions about transmission
por: Prazuck, Thierry, et al.
Publicado: (2020)

Residual Viremia in Treated HIV(+) Individuals
por: Conway, Jessica M., et al.
Publicado: (2016)

A Mature NK Profile at the Time of HIV Primary Infection Is Associated with an Early Response to cART
por: Gondois-Rey, Françoise, et al.
Publicado: (2017)

Lopinavir to atazanavir or darunavir switch in HIV-1-infected patients with dyslipidemia: an observational study
por: Le Moal, G, et al.
Publicado: (2010)

P04-17. The N-glycosylation sites N295, N332 and N392 of gp120 are necessary but not sufficient for HIV-1 to be neutralized by 2G12
por: Chaillon, A, et al.
Publicado: (2009)

Modeling the kinetics of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2
por: Clairon, Quentin, et al.
Publicado: (2023)

Prolonged Antiretroviral Treatment Induces Adipose Tissue Remodelling Associated with Mild Inflammation in SIV-Infected Macaques
por: Mausoléo, Aude, et al.
Publicado: (2022)

Antiretroviral therapy for HIV controllers: Reasons for initiation and outcomes in the French ANRS-CO21 CODEX cohort
por: Plaçais, Léo, et al.
Publicado: (2021)

Residual Viremia Is Preceding Viral Blips and Persistent Low-Level Viremia in Treated HIV-1 Patients
por: Hofstra, Laura Marije, et al.
Publicado: (2014)

Bocavirus viremia
por: Sukkaromdee, Pathoom, et al.
Publicado: (2015)

Impact de la prévalence du COVID-19 des personnels d’établissements médicosociaux sur le risque d’infection des résidents : étude prospective dans 17 EHPAD et MAS
por: Sève, A., et al.
Publicado: (2020)

Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment
por: Aamer, Hadega A., et al.
Publicado: (2020)

A Single HIV-1 Cluster and a Skewed Immune Homeostasis Drive the Early Spread of HIV among Resting CD4+ Cell Subsets within One Month Post-Infection
por: Bacchus, Charline, et al.
Publicado: (2013)

High Prevalence of Cervical High-Risk Human Papillomavirus Harboring Atypical Genotypes in Human Immunodeficiency Virus -Infected and -Uninfected First-Generation Adult Immigrant Women Originating from Sub-Saharan Africa and Living in France
por: Mboumba Bouassa, Ralph-Sydney, et al.
Publicado: (2020)

SARS-CoV-2 Infection in Ivory Coast: A Serosurveillance Survey among Gold Mine Workers
por: Milleliri, Jean Marie, et al.
Publicado: (2021)

Bird species define the relationship between West Nile viremia and infectiousness to Culex pipiens mosquitoes
por: Vaughan, Jefferson A., et al.
Publicado: (2022)

Retrospective and prospective studies evaluating the performance of the SARS-Cov-2 “AQ+ COVID-19 Ag Rapid Test” from InTec on symptomatic and non-symptomatic patients
por: Prazuck, Thierry, et al.
Publicado: (2023)

Sequential treatment with 5‐aza‐2′‐deoxycytidine and deacetylase inhibitors reactivates HIV‐1
por: Bouchat, Sophie, et al.
Publicado: (2015)

VIREMIA IN HUMAN POLIOMYELITIS
por: Horstmann, Dorothy M., et al.
Publicado: (1954)

Cannot write session to /tmp/vufind_sessions/sess_vp102loq111eh1bosgstq4mgmg